Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | BMY | AMGN | GILD | MRNA |
| Company | Cara Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7559 | 43.97 | 274.18 | 65.32 | 111.11 |
| High | 0.7770 | 44.47 | 279.84 | 65.89 | 113.73 |
| Low | 0.7225 | 43.73 | 273.38 | 64.97 | 109.00 |
| Last | 0.7586 | 44.21 | 277.37 | 65.51 | 111.46 |
| Change | +0.0067 | +0.27 | +3.43 | +0.31 | +1.15 |
| % Change | +0.89% | +0.61% | +1.25% | +0.48% | +1.04% |
| Volume | 190,411 | 13,245,334 | 2,322,949 | 7,228,683 | 3,830,808 |
| 20-Day Average Volume | 335,976 | 14,065,432 | 2,242,988 | 7,433,584 | 3,000,811 |
| Previous Close | 0.7519 | 43.94 | 273.94 | 65.20 | 110.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7503 | 48.21 | 269.69 | 67.33 | 106.22 |
| 20-Day Raw Stochastic | 40.62% | 5.77% | 87.11% | 13.02% | 73.30% |
| 20-Day Relative Strength | 48.80% | 28.67% | 52.79% | 32.15% | 58.03% |
| Weighted Alpha | -73.49 | -36.23 | +14.56 | -21.43 | -7.05 |
| Today's Opinion | 72% Sell | 88% Sell | 24% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 40% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 16% Sell | 8% Sell | 8% Sell | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.95% since 04/24/24 | -9.52% since 04/24/24 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | +2.40% since 04/24/24 |
| Low | 0.6400 on 04/25/24 | 43.73 on 05/01/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 103.52 on 04/25/24 |
| High | 0.7875 on 04/30/24 | 47.50 on 04/25/24 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 113.73 on 05/01/24 |
| 1-Month | |||||
| %Chg | -16.64% since 04/01/24 | -16.57% since 04/01/24 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | +5.55% since 04/01/24 |
| Low | 0.6311 on 04/16/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 97.00 on 04/03/24 |
| High | 0.9490 on 04/03/24 | 53.35 on 04/02/24 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +35.25% since 02/01/24 | -9.16% since 02/01/24 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | +12.56% since 02/01/24 |
| Low | 0.5150 on 02/08/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 84.06 on 02/13/24 |
| High | 1.1500 on 03/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | -37.31% since 11/01/23 | -13.79% since 11/01/23 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | +46.27% since 11/01/23 |
| Low | 0.5000 on 01/25/24 | 43.73 on 05/01/24 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 62.55 on 11/02/23 |
| High | 1.4000 on 11/06/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 41,104 | 89,070,768 | 146,934,848 | 81,179,024 | 42,235,488 |
| Shares Outstanding, K | 54,667 | 2,027,100 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 20,970,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -118,510,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 3,000,000 | 11,865,000,000 | 8,196,000,000 | 6,686,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -32,340,000 | -11,911,000,000 | 767,000,000 | -4,170,000,000 | 217,000,000 |
| 60-Month Beta | 0.70 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.51 | 14.82 | 16.36 | 0.00 |